JPMorgan Funds - Thematics - Genetic Therapies A (dist) - USD
WKN A2PR3Q | ISIN LU2053352691 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0208607159 | Pictet - Biotech - P dy USD | +69,74 % | +21,63 % | 3,12 |
|
| 2 | LU0108459552 | Candriam Equities L Biotechnology, C - Distribution | +63,28 % | +20,50 % | 2,98 |
|
| 3 | LU0320646986 | Pictet - Biotech - P dy GBP | +66,96 % | +21,95 % | 2,95 |
|
| 4 | IE00BF23BV98 | Polar Capital Funds plc - Biotechnology Fund Class S USD Distribution Shares | +68,77 % | +24,76 % | 2,70 |
|
| 5 | IE00B42Z4531 | Polar Capital Funds plc - Biotechnology Fund Class I USD Distribution Shares | +68,39 % | +24,77 % | 2,68 |
|
| 10 | LU2053352691 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - USD | +39,78 % | +20,57 % | 1,83 |
|
| 14 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | +34,39 % | +20,33 % | 1,58 |
|
| 15 | AT0000746748 | ERSTE STOCK BIOTEC EUR R01 (A) | +30,20 % | +19,70 % | 1,42 |
|
| 16 | DE000A2DU172 | Allianz Biotechnologie - P - EUR | +28,02 % | +20,31 % | 1,27 |
|
| 17 | DE000A2AMPU5 | Allianz Biotechnologie - R - EUR | +27,88 % | +20,31 % | 1,26 |
|
| 18 | DE0008481862 | Allianz Biotechnologie - A - EUR | +26,77 % | +20,31 % | 1,21 |
|